UCB acquires majority stake in Meizler
11:51 EDT 1 Jun 2012 | Current Partnering
UCB takes majority stake in Brazil’s Meizler. UCB has expanded its presence in the emerging markets by acquiring a majority stake in Brazilian drugmaker Meizler Biopharma. The Belgian group is taking an initial 51% stake in the privately-owned Sao Paulo-headquartered company. Under the terms of the deal, the financial details for which have not been [...
Original Article: UCB acquires majority stake in Meizler
More From BioPortfolio on "UCB acquires majority stake in Meizler"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
